Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulse Biosciences' CellFX nsPFA Cardiac Surgery Clamp System for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery

NCT06959121 is registered in ClinicalTrials.gov with Pulse Biosciences, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06959121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulse Biosciences' CellFX nsPFA Cardiac Surgery Clamp System for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery
Lead sponsor
Pulse Biosciences, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
October 23, 2025
Completion date
December 31, 2028
Enrollment
135 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ablation, af, atrial fibrillation, maze procedure